My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 284

    1.

    Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection.

    de Almeida KN, Bush LM.

    Ann Intern Med. 2006 Aug 1;145(3):231-2; author reply 232-3. No abstract available. PMID: 16880468 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection.

    Johnson JR.

    Ann Intern Med. 2006 Aug 1;145(3):232; author reply 232-3. No abstract available. PMID: 16880472 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.

    Fergie J, Purcell K.

    Pediatr Infect Dis J. 2008 Jan;27(1):67-8. Review. No abstract available. PMID: 18162942 [PubMed - indexed for MEDLINE]Related articles

    4.

    Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

    Creech CB, Beekmann SE, Chen Y, Polgreen PM.

    Pediatr Infect Dis J. 2008 Mar;27(3):270-2.PMID: 18277924 [PubMed - indexed for MEDLINE]Related articles

    5.

    Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).

    Itani KM, Weigelt J, Li JZ, Duttagupta S.

    Int J Antimicrob Agents. 2005 Dec;26(6):442-8. Epub 2005 Nov 10.PMID: 16289514 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?

    Kalil AC, Puumala S, Stoner J.

    Antimicrob Agents Chemother. 2006 May;50(5):1910; author reply 1910-1. No abstract available. PMID: 16641477 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    First detected case of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infection in Italy.

    Tinelli M, Pantosti A, Lusardi C, Vimercati M, Monaco M.

    Euro Surveill. 2007 Apr 12;12(4):E070412.1. No abstract available. PMID: 17439803 [PubMed - indexed for MEDLINE]Related articles

    8.

    Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

    Hyun DY, Mason EO, Forbes A, Kaplan SL.

    Pediatr Infect Dis J. 2009 Jan;28(1):57-9.PMID: 19057459 [PubMed - indexed for MEDLINE]Related articles

    9.

    Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin.

    Barnes EV 2nd, Dooley DP, Hepburn MJ, Baum SE.

    Mil Med. 2006 Jun;171(6):504-7.PMID: 16808130 [PubMed - indexed for MEDLINE]Related articles

    10.

    Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

    Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C; Linezolid CSSTI Study Group.

    Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6.PMID: 15917519 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

    Whitman TJ.

    Dis Mon. 2008 Dec;54(12):780-6. Review. No abstract available. PMID: 18996280 [PubMed - indexed for MEDLINE]Related articles

    12.

    Skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.

    Graber C.

    BETA. 2007 Summer;19(4):20-6.PMID: 18069153 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antibiotic options for treating community-acquired MRSA.

    Powell JP, Wenzel RP.

    Expert Rev Anti Infect Ther. 2008 Jun;6(3):299-307. Review.PMID: 18588495 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?

    Howden BP, Charles PG, Johnson PD, Ward PB, Grayson ML.

    Antimicrob Agents Chemother. 2005 Nov;49(11):4816; author reply 4816-7. No abstract available. PMID: 16251343 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.

    Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ.

    J Clin Microbiol. 2007 Jun;45(6):1705-11. Epub 2007 Mar 28.PMID: 17392441 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).

    Charalampidou S, Connell P, Fennell J, Lynch M, Acheson R.

    Br J Ophthalmol. 2007 Dec;91(12):1723-4. No abstract available. PMID: 18024828 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.

    Widmer AF.

    Clin Infect Dis. 2008 Mar 1;46(5):656-8. Review. No abstract available. PMID: 18225983 [PubMed - indexed for MEDLINE]Related articles

    18.

    Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.

    Marcinak JF, Frank AL.

    Expert Rev Anti Infect Ther. 2006 Feb;4(1):91-100. Review.PMID: 16441212 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK.

    Enoch DA, Karas JA, Aliyu SH.

    Int J Antimicrob Agents. 2009 Jun;33(6):497-502. Epub 2008 Dec 20. Review.PMID: 19101123 [PubMed - indexed for MEDLINE]Related articles

    20.

    Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.

    Bassetti M, Di Biagio A, Del Bono V, Cenderello G, Bassetti D.

    Int J Antimicrob Agents. 2004 Jul;24(1):83-4.PMID: 15225867 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity